[PDF][PDF] P76. 87 Efficacy of Dacomitinib in EGFR TKI Refractory Metastatic Non-Small Cell Lung Cancer (EGFR Mutant) with Leptomeningeal Metastases
D Chan - researchgate.net
Introduction: Leptomeningeal disease in metastatic non-small cell lung cancer remains a
challenging condition with guarded prognosis. Although several EGFR TKI (in particular …
challenging condition with guarded prognosis. Although several EGFR TKI (in particular …
P76. 87 Efficacy of Dacomitinib in EGFR TKI Refractory Metastatic Non-Small Cell Lung Cancer (EGFR Mutant) with Leptomeningeal Metastases
D Chan - Journal of Thoracic Oncology, 2021 - Elsevier
Methods This is a patient treated in a private medical oncology centre in Singapore by a
medical oncologist. The patient and family agreed to off-label use of dacomitinib in …
medical oncologist. The patient and family agreed to off-label use of dacomitinib in …
P76. 87 Efficacy of Dacomitinib in EGFR TKI Refractory Metastatic Non-Small Cell Lung Cancer (EGFR Mutant) with Leptomeningeal Metastases
D Chan - Journal of Thoracic Oncology, 2021 - jto.org
Methods This is a patient treated in a private medical oncology centre in Singapore by a
medical oncologist. The patient and family agreed to off-label use of dacomitinib in …
medical oncologist. The patient and family agreed to off-label use of dacomitinib in …